A patient population admitted to the hospital for either SLE or RA was surveyed for the subsequent development of neoplasms. The frequency of neoplasm in SLE patients appeared to be exaggerated, whereas the frequency of subsequent neoplasm in rheumatoid patients was unexpectedly low. A paucity of nephritis in the SLE group was noted. Further reports are encouraged so that the magnitude of the risk of malignancy developing with immunosuppressive therapy can be more precisely ascertained.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/37730/1/1780190605_ftp.pd
A Review based on a Dissertation read before the Society on Friday. 29th November, 1964.Not even the...
Objective To examine disease activity versus treatment as lymphoma risk factors in systemic lupus er...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Relatively sparse literature developed during the past 30 years that sought to characterize the rela...
Malignancy as a cause of death was reported in occasional SLE patients, but the question whether pat...
A retrospective study of the incidence of rheumatoid arthritis and systemic malignancy was performed...
SUMMARY A consecutive series of 489 patients with rheumatoid arthritis seen at the centre was studie...
Objective: To update estimates of cancer risk in SLE relative to the general population. Methods: A ...
Introduction Rheumatic diseases (RDs) are associated with different cancers; howeve...
Concern exists that individuals with systemic lupus erythematosus (SLE) have increased susceptibili...
Copyright © 2009 The Journal of Rheumatology. All rights reserved.Objective. Features of systemic lu...
Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease, characterized by a...
Evidence points to a decreased breast cancer risk in systemic lupus erythematosus (SLE). We analyzed...
The objective of this study was to evaluate the incidence of malignancies among newly diagnosed syst...
Objective: The aim of this study was to assess the cancer risk in a cohort of Finnish systemic lupus...
A Review based on a Dissertation read before the Society on Friday. 29th November, 1964.Not even the...
Objective To examine disease activity versus treatment as lymphoma risk factors in systemic lupus er...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Relatively sparse literature developed during the past 30 years that sought to characterize the rela...
Malignancy as a cause of death was reported in occasional SLE patients, but the question whether pat...
A retrospective study of the incidence of rheumatoid arthritis and systemic malignancy was performed...
SUMMARY A consecutive series of 489 patients with rheumatoid arthritis seen at the centre was studie...
Objective: To update estimates of cancer risk in SLE relative to the general population. Methods: A ...
Introduction Rheumatic diseases (RDs) are associated with different cancers; howeve...
Concern exists that individuals with systemic lupus erythematosus (SLE) have increased susceptibili...
Copyright © 2009 The Journal of Rheumatology. All rights reserved.Objective. Features of systemic lu...
Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease, characterized by a...
Evidence points to a decreased breast cancer risk in systemic lupus erythematosus (SLE). We analyzed...
The objective of this study was to evaluate the incidence of malignancies among newly diagnosed syst...
Objective: The aim of this study was to assess the cancer risk in a cohort of Finnish systemic lupus...
A Review based on a Dissertation read before the Society on Friday. 29th November, 1964.Not even the...
Objective To examine disease activity versus treatment as lymphoma risk factors in systemic lupus er...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...